Synta Pharmaceuticals Revenue TTM:
0.00 for March 31, 2013Synta Pharmaceuticals Historical Revenue TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.00 |
| Dec. 31, 2012 | 0.147M |
| Sept. 30, 2012 | 3.57M |
| June 30, 2012 | 5.234M |
| March 31, 2012 | 6.588M |
| Dec. 31, 2011 | 7.584M |
| Sept. 30, 2011 | 8.198M |
| June 30, 2011 | 9.917M |
| March 31, 2011 | 11.92M |
| Dec. 31, 2010 | 14.80M |
| Sept. 30, 2010 | 15.45M |
| June 30, 2010 | 142.47M |
| March 31, 2010 | 143.76M |
| Dec. 31, 2009 | 144.24M |
| Sept. 30, 2009 | 140.20M |
| June 30, 2009 | 11.07M |
| March 31, 2009 | 7.756M |
| Dec. 31, 2008 | 4.584M |
About Revenues (TTM)
SNTA Revenue TTM Benchmarks
| Companies | |
|---|---|
| Trinity Biotech | 82.51M |
| SurModics | 53.86M |
| Quidel Corporation | 179.78M |
SNTA Revenue TTM Rankings
| Overall |
37th percentile 4985 of 8002 |
| Sector |
17th percentile 539 of 650 in Healthcare |
| Industry |
9th percentile 55 of 61 in Diagnostics & Research |
SNTA Revenue TTM Range, Past 5 Years
| Minimum | 0.00 | Mar 2013 |
| Maximum | 144.25M | Dec 2009 |
| Average | 37.64M |
SNTA News
Synta Pharma (SNTA) Sell-Off Related to R&D Pres. Resignation, Could Be Buying Opp
Street Insider May 7
Street Insider May 7